• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate (CAS No. 638218-70-9): A Comprehensive Overview

Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate (CAS No. 638218-70-9) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and chemical synthesis. This compound, characterized by its unique benzofuran core structure, possesses a variety of potential applications, particularly in the development of bioactive molecules and drug candidates. The detailed exploration of its chemical properties, synthetic pathways, and emerging applications in medicinal chemistry provides a comprehensive understanding of its significance.

The molecular structure of Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate features a benzofuran ring system substituted with a hydroxyl group at the 6-position and a methyl group at the 2-position, coupled with a carboxylate ester moiety at the 3-position. This arrangement contributes to its distinct reactivity and interaction capabilities with biological targets. The presence of both hydroxyl and methyl groups enhances its potential as a scaffold for further derivatization, making it a valuable building block in the synthesis of more complex pharmacophores.

In recent years, there has been growing interest in exploring the pharmacological potential of benzofuran derivatives. Studies have demonstrated that compounds featuring this core structure exhibit diverse biological activities, including anti-inflammatory, antioxidant, and anticancer properties. The hydroxyl group in particular plays a crucial role in modulating these activities by facilitating hydrogen bonding interactions with biological targets. Furthermore, the ester functionality at the 3-position provides a versatile handle for chemical modifications, enabling the design of novel analogs with enhanced potency and selectivity.

One of the most compelling aspects of Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate is its utility as a precursor in the synthesis of more complex molecules. Researchers have leveraged its structural features to develop novel drug candidates targeting various therapeutic areas. For instance, derivatives of this compound have shown promise in inhibiting key enzymes involved in cancer progression, such as kinases and proteases. The ability to modify different functional groups on the benzofuran core allows for fine-tuning of biological activity, making it an indispensable tool in medicinal chemistry.

The synthetic pathways for preparing Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate are well-documented and have been optimized for efficiency and scalability. Common synthetic routes involve multi-step organic transformations, starting from readily available aromatic precursors. These methods often include cyclization reactions to form the benzofuran ring system, followed by functional group interconversions to introduce the hydroxyl and ester moieties. Advances in synthetic methodologies have further streamlined these processes, making it feasible to produce this compound in larger quantities for research and development purposes.

Recent studies have also highlighted the importance of understanding the metabolic fate of benzofuran derivatives. Pharmacokinetic studies indicate that compounds like Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate are metabolized through various pathways, including oxidation and conjugation reactions. These metabolic processes can significantly influence their bioavailability and therapeutic efficacy. By elucidating these pathways, researchers can design molecules with improved pharmacokinetic profiles, enhancing their potential as viable drug candidates.

The role of computational chemistry in studying Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate cannot be overstated. Advanced computational techniques, such as molecular modeling and quantum mechanics simulations, have provided valuable insights into its interactions with biological targets. These studies help predict binding affinities and identify key residues involved in receptor binding. By integrating computational data with experimental findings, researchers can accelerate the discovery process and optimize lead compounds for clinical development.

In conclusion, Methyl 6-hydroxy-2-methylbenzofuran-3-carboxylate (CAS No. 638218-70-9) represents a significant advancement in pharmaceutical chemistry due to its versatile structure and potential applications. Its unique benzofuran core offers a rich framework for designing bioactive molecules with diverse therapeutic effects. As research continues to uncover new synthetic strategies and pharmacological properties, this compound is poised to play an increasingly important role in drug discovery and development.

• 7287-40-3(ethyl 5-hydroxy-2-methyl-benzofuran-3-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)